Capital Research Global Investors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.17B | Buy |
|
|||||
|
2025
Q1 | $7.05B | Buy |
|
|||||
|
2024
Q4 | $4.2B | Buy |
|
|||||
|
2024
Q3 | $4.19B | Buy |
|
|||||
|
2024
Q2 | $4B | Buy |
|
|||||
|
2024
Q1 | $2.4B | Buy |
|
|||||
|
2023
Q4 | $1.45B | Buy |
|
|||||
|
2023
Q3 | $1.17B | Buy |
|
|||||
|
2023
Q2 | $1.08B | Buy |
|
|||||
|
2023
Q1 | $255M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $340M | Sell |
|
|||||
|
2020
Q2 | $363M | Sell |
|
|||||
|
2020
Q1 | $298M | Buy |
|
|||||
|
2019
Q4 | $274M | Buy |
|
|||||
|
2019
Q3 | $212M | Buy |
|
|||||
|
2019
Q2 | $229M | Buy |
|
|||||
|
2019
Q1 | $230M | Sell |
|
|||||
|
2018
Q4 | $342M | Sell |
|
|||||
|
2018
Q3 | $512M | Buy |
|